Table 3.

Relationship between the expressions of syndecan-1, E-cadherin and integrin β3 and the prognosis of gastric carcinoma patients

Groups	n	Mean survival time (mo)	5-yr survival rate (%)	χ2	P
Syndecan-1 expression
Low expression	68	32.10 ± 4.16	12.80	53.13	0
High expression	50	123.80 ± 5.56	91.66
E-cadherin expression
Low expression	68	33.69 ± 4.33	12.80	43.36	0
High expression	50	119.78 ± 5.87	93.59
Integrin β3 expression
Low expression	59	103.30 ± 7.73	72.75	35.11	0
High expression	59	33.12 ± 4.64	13.85